Potent suppression of CD4+ and CD8+ T-lymphocyte proliferation and activation could, over time, induce inadequate immune surveillance of hepatic damage, making patients more susceptible to NAFLD progression. Here, CD8A is linked to metabolic dysfunction-associated steatotic liver disease.